Specialty drugs: Abarca is mainly focused on ... particularly with the Big Three PBMs (CVS Caremark, Express Scripts and Optum Rx). The FTC has been investigating them, and several bills have ...
Prescription medication is counted before being placed into a bottle for customer pickup on Friday, Nov. 10, 2023. (Geoff ...
Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
Zacks Investment Research on MSN5d
CAH Stock Up Nearly 7% This Year: Is Now the Time to Buy?Cardinal Health Inc. CAH is well-poised for growth, given its long-term supply agreements, diversified product portfolio and ...
The company also showed its strengths beyond this specialty area, collecting approvals for a gene-editing therapy for blood disorders a little over a year ago and a pain treatment just recently.
3 In January, Amgen launched Wezlana through an exclusive agreement with Nuvalia, Optum Rx’s biosimilar procurement business, similar to CVS Health's Cordavis and Cigna/Express Scripts' Quallent. 4 ...
After hours: March 11 at 7:10:05 PM EDT Loading Chart for SKWD ...
Pre-market: 4:10:49 am GMT-4 Loading Chart for UNH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback